首页 > 市场调查报告书 > 医疗设备

病患监测体外诊断血糖监测

市场调查报告书

商品编码

1789605

持续血糖监测设备市场（按组件、最终用户和地区）

Continuous Glucose Monitoring Devices Market, By Component (Sensors, Transmitters, and Receivers), By End User (Hospitals, Home care, and Others), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

出版日期: 2025年07月30日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年连续血糖监测设备市场规模为 78.1 亿美元，到 2032 年将达到 151.2 亿美元，2025 年至 2032 年的复合年增长率为 9.9%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	78.1亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年	9.90%	2032年预测	151.2亿美元

连续血糖监测（CGM）设备是糖尿病患者用来持续监测血糖值的医疗设备。随着全球糖尿病盛行率的不断上升，全球对CGM设备的需求也迅速成长。

市场动态

糖尿病盛行率上升、老年人口成长、对 CGM 的需求上升、技术先进设备的采用率增加以及全球人民意识的提高是预计将促进全球连续血糖监测设备市场成长的关键因素。

例如，2023年5月，健康科技公司January AI推出了一款基于生成式人工智慧(AI)的全新应用程序，该应用程式可以估算和预测个人对超过320亿种食物的血糖反应。此工具只需使用者穿戴一次CGM，即使使用者未使用CGM也能正常运作。该平台旨在持续为用户提供血糖估计值、预测和关键洞察等资讯。使用者还可以获得关于增加纤维消费量、建议卡路里摄取量、间歇性断食、减少血糖飙升食物、饭后散步等方面的洞察。

本次调查的主要特点

本报告对全球连续血糖监测设备市场进行了详细分析，并提供了预测期 2025-2032 的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。
它揭示了不同领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
全球连续血糖监测设备市场的主要企业会根据以下参数进行分析，例如公司亮点、产品系列、关键亮点、财务表现和策略。
预计本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过全球连续血糖监测设备市场分析中使用的各种策略矩阵更轻鬆地做出决策。

介绍
北美洲
- 美国
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 东南亚国协
- 其他亚太地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
非洲
- 南非
- 北非
- 中部非洲

第七章竞争态势

Medtronic
Dexcom, Inc.
Abbott
Novo Nordisk A/S
Ypsomed
GlySens Incorporated
F. Hoffmann-La Roche Ltd.

第 8 章章节

调查方法
关于出版商

简介目录

Product Code: CMI57

Continuous Glucose Monitoring Devices Market is estimated to be valued at USD 7.81 Bn in 2025 and is expected to reach USD 15.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 7.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.90%	2032 Value Projection:	USD 15.12 Bn

Continuous glucose monitor (CGM) is a medical device used by people with diabetes to monitor blood sugar (glucose) on a continual basis, e.g. people with type I, type II diabetes, or other types of diabetes (e.g. gestational diabetes). Thus, with the increasing prevalence of diabetes across the globe, the demand for CGM devices is also increasing rapidly, worldwide.

Market Dynamics

Increasing prevalence of diabetes, growing geriatric population, increasing demand for continuous glucose monitors (CGM), increasing adoption of technologically advanced devices, and increasing awareness among people across the globe are major factors expected to augment the growth of thelobal continuous glucose monitoring devices market.

For instance, in May 2023, Health tech company, January AI, introduced a new generative artificial intelligence (AI)-enabled app to estimate and predict the glucose response of individuals to more than 32 Bn food items. The tool requires users to wear a CGM only once and it can function even if members are not using a CGM. The platform is designed to provide users with information such as glucose estimates, predictions and key insights on an ongoing basis. Users also receive insights on increasing fibre consumption, calorie recommendations, intermittent fasting, lowering glucose-spiking foods, and getting post-meal walks.

Key features of the study

This report provides in-depth analysis of the global continuous glucose monitoring devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global continuous glucose monitoring devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Medtronic, Dexcom, Inc., Abbott, Novo Nordisk A/S, Ypsomed, GlySens Incorporated, and F. Hoffmann-La Roche Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous glucose monitoring device market.

Market Segmentation

Global Continuous Glucose Monitoring Devices Market, By Component
- Sensors
- Transmitters
- Receivers
Global Continuous Glucose Monitoring Devices Market, By End User
- Hospitals
- Home care
- Others
Global Continuous Glucose Monitoring Devices Market, By Geography
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Medtronic
- Dexcom, Inc.
- Abbott
- Novo Nordisk A/S
- Ypsomed
- GlySens Incorporated
- Hoffmann-La Roche Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of diabetes around the world
- High cost of continuous glucose monitors
- Increasing demand for continuous glucose monitors
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Continuous Glucose Monitoring Devices Market, By Component, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transmitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Receivers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Continuous Glucose Monitoring Devices Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Continuous Glucose Monitoring Devices Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dexcom, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ypsomed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlySens Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

8. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

持续血糖监测设备市场（按组件、最终用户和地区）

Continuous Glucose Monitoring Devices Market, By Component (Sensors, Transmitters, and Receivers), By End User (Hospitals, Home care, and Others), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

市场动态